Agenda
2025 ARA Annual Conference Agenda*
All CME sessions will take place in the Columbia Ballroom. All meals and product theaters and will take place in Kahiltna Court. There are 10 sessions available for CME credit and the schedule and/or order is subject to change.
*Indicates CME session
Friday, March 21, 2025
12:00-2:00 Vendor Setup
1:30-2:30 Attendee Check-in (Columbia Ballroom)
Badge and tram ticket provided at check-in
2:30-3:30* Session 1: 2025 Update: Artificial Intelligence in Rheumatology
Orrin Troum, M.D., M.A.C.R
Clinical Professor of Medicine
Keck School of Medicine, University of Southern California
Director of Rheumatology Clinical Research, Providence Saint John's Health Center
3:30-4:00 Hotel Check-in/Break/Exhibits
4:00-5:00. Product Theater Presentation by UCB
BIMZELX HAS ARRIVED IN RHEUMATOLOGY In addition to Moderate-to Severe PSO, BIMZELX Is Now
Approved in PsA, nr-axSpA, and AS
Jeff Regan Peterson, M.D.
Western Washington Medical Group
5:00-6:00 Tram to Seven Glaciers
6:00-7:00 Welcome Reception at Seven Glaciers
7:00-9:00 Opening Remarks and Welcome Dinner at Seven Glaciers
Saturday, March 22, 2025
8:00-9:00 Breakfast/Product Theater Presentation by Sanofi
The History, the Present, the Future: KEVZARA (sarilumab®) is Now Approved In pJIA, In Addition to PMR
and RA
Orrin M. Troum, M.D., M.A.C.R
Clinical Professor of Medicine, Keck School of
Medicine / University of Southern California, Director of Rheumatology Clinical
Research Providence Saint John's Health Center
9:00-10:00* Session 2: Advocacy in Rheumatology, the 2025 Edition
Christina Downey, M.D., F.A.C.R. DipABLM RhMSUS CCD
Associate Professor, Department of Medicine
Chair, Division of Rheumatology
Chair, Government Affairs Committee, American College of Rheumatology
10:00-11:00* Session 3: Where Worlds Collide: Cutaneous Psoriasis Tips and Tricks
Kristin Eastman, M.D., F.A.A.D.
Swiftwater Dermatology
Rechelle Tull, M.D., F.A.A.D.
Alaska Skin Surgery and Aesthetics
11:00-11:30 Break/Exhibits
11:30-12:30* Session 4: Positioning Biologic Therapy in IBD with Associated Rheumatologic Disorder
Austin T. Nelson, M.D.
Alaska Digestive and Liver Disease
12:30-1:30 Lunch/Product Theater Presentation by Abbvie
Rinvoq for SpA
Gregory DeLorenzo, M.D.
Rheumatologist
TriHealth Physicians Partners
Group Health Rheumatology, Ohio Association of Rheumatology Board Member
1:30-2:00 Break/Exhibits
2:00-3:00* Session 5: Electrolyte FUN
Jeremy Gitomer, M.D.
Kidney and Hypertension Clinic of Alaska
3:00-4:00* Session 6: Adrenal Insufficiency for the Uninterested
Jeffrey Medland, D.O.
Internal Medicine - Endocrinology, Diabetes & Metabolism
4:00-4:30 Break/Exhibits
4:30-5:30* Session 7: Use of Diabetes and Weight Loss Therapies in Rheumatology
Orrin M. Troum, M.D., M.A.C.R.
Clinical Professor of Medicine
Keck School of Medicine / University of Southern California
Director of Rheumatology Clinical Research Providence Saint John's Health Center
6:00-7:30 Closeout Reception in Columbia Ballroom Foyer
Sunday, March 23, 2025
8:30-9:30 Breakfast/Product Theater Presentation by Alexion
Get Straight to the Source of Hypophosphatasia
Rachel Lombardo, M.D.
Phoenix Children’s Hospital
9:30-10:30 Immuno-Autonomics. What is it? Why Do We Care? How Can It Be Used To Assist In The
Treatment of RA
Richard Jimenez, MD
Western Washington Arthritis Clinic
Western Washington Medical Group
10:30-11:00 Hotel Checkout/Breaks/Exhibits
11:00-12:00* Session 8: Panel-Treatment Approaches for the Non-Rheumatologist
12:00-1:00 Lunch and Product Theater Presentation by Novartis
COSENTYX® (secukinumab) Cases: An Interactive Game-Based Challenge
About Psoriatic Arthritis and Ankylosing Spondylitis
Stan Read
Associate Director, Thought Leader Liaison
1:00-2:00* Session 9: ANA
Ryan Ragle, M.D.
Rheumatologist
OPA Rheumatology and Infusion
2:00-2:30 Closing Comments
Designation Statement: The Indiana State Medical Association (ISMA) designates this live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the ISMA and the Alaska Rheumatology Alliance. The ISMA is accredited by the ACCME to provide continuing medical education for physicians.